FORM4API
ExploreSearch any ticker for its insider tradesFilingsThe newest Form 4 filings, market-wideForm 144Intent to sell, filed before the trade13F FilersInstitutional 13F-HR filers by AUMSignalsCluster buy & sell signalsScreenerFilter trades by code, size & returnCongressSTOCK Act trades disclosed by Congress
PricingDocs
SEC Form 4 explainedSEC Form 144 explained13F-HR filings explainedCluster buy signals10b5-1 trading plans
All guides →
Sign inGet a keyDashboard

Company profile

OnKure Therapeutics, Inc. Insider Trading

OKUR

Every SEC Form 4 insider trading filing for OnKure Therapeutics, Inc. (OKUR) since April 2023: open-market buys and sells by directors and officers, option exercises, and cluster activity, updated as each filing is reported to the SEC. Why 2023?

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
CIK
0001637715
Filings
84
Insiders
29
Last filing
2026-08-07
SEC EDGAR ↗Yahoo Finance ↗Finviz ↗Stock Analysis ↗

Activity summary

No insider transactions in the last 30 days. The most recent was on August 7, 2026, when Samuel Agresta bought 50,000 shares. 84 filings from 29 insiders are on record below.

Three year balance

Buy and sell value by quarter, Q4 23 to Q3 26. OnKure Therapeutics, Inc. insiders are net buyers across the period shown.

PurchasesSales
Q4 23Q1 24Q2 24Q3 24Q4 24Q1 25$3.4MQ2 25Q3 25Q4 25Q1 26Q2 26Q3 26

Bars below the rule are sales, above are purchases. Largest quarter on the chart is $3.4M.

90 day insight

Over the last 90 days, OnKure Therapeutics, Inc. insiders bought $0 (21 transactions) and sold $0 (11 transactions).

  • Most active insider: Nicholas A Saccomano with 11 transactions totaling $0.

Activity skews bullish: buys outpace sales.

Insider Transactions

Sourced from SEC EDGAR Form 4 filings. Updated hourly.

DateInsiderCompanyTypeSharesPriceValueReturn
Aug 7, 2026Samuel AgrestaOKUR
Award
50,000——-18.6% 1m
Aug 7, 2026Samuel AgrestaOKUR
Disposition
18,588——-18.6% 1m
Aug 7, 2026Samuel AgrestaOKUR
Award
18,588——-18.6% 1m
Aug 7, 2026Samuel AgrestaOKUR
Disposition
131,396——-18.6% 1m
Aug 7, 2026Samuel AgrestaOKUR
Award
131,396——-18.6% 1m

45 more transactions hidden

Free account · No credit card required

Building something? Get API access →

Query this yourself

The same rows, over the API.

curl "https://api.form4api.com/v1/transactions?ticker=OKUR" \
  -H "X-Api-Key: $KEY"
Get a key

Top insiders

By total value filed.

Jason A. LeveroneChief Financial Officer3 filings−$3K
Nicholas A SaccomanoPresident and CEO2 filings−$736

Institutional Ownership

Top 13F-HR holders of OnKure Therapeutics, Inc. as of 2026-06-30

— stable
Total reported AUM
$11.2M
QoQ change
—
Reporting period
2026-06-30
#1
BlackRock, Inc.
CIK 0002012383
$3.6M
793K shares
#2
BlackRock, Inc.
CIK 0002012383
$2.7M
591K shares
#3
State Street Corp
CIK 0000093751
$2.1M
464K shares

Data source: quarterly 13F-HR filings: institutional holders report positions within 45 days of quarter end. Joined with insider activity above: see who's loading up institutionally while insiders are trading. Full 13F-HR API →

FORM4API

Real-time SEC Form 4, Form 144, 13F-HR and congressional trading data, over a REST API and webhooks.

Data
  • Screener
  • Filings
  • Signals
  • Companies
  • Insiders
  • Congress trades
  • 13F filers
  • Explorer
  • Top insiders
Developers
  • Documentation
  • Insider trading API
  • Python SDK
  • TypeScript SDK
  • MCP server
  • Status
Company
  • Pricing
  • Guides
  • Compare
  • About
  • Data quality
  • Privacy
  • Terms
Form4API, StockholmNot affiliated with the SEC or EDGAR. Data sourced from public EDGAR filings. Not investment advice.

Popular companies on Form4API

Browse insider trading activity for other actively-filed companies.

TEAMAtlassian CorpLEGLeggett & Platt IncVZVerizon Communications IncTPLTexas Pacific Land CorpCRMSalesforce, Inc.RCGRENN Fund, Inc.METAMeta Platforms, Inc.ACNAccenture plcPPGPpg Industries IncNFLXNetflix IncCHDChurch & Dwight Co Inc /de/